[go: up one dir, main page]

PE20010303A1 - Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido - Google Patents

Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido

Info

Publication number
PE20010303A1
PE20010303A1 PE2000000565A PE0005652000A PE20010303A1 PE 20010303 A1 PE20010303 A1 PE 20010303A1 PE 2000000565 A PE2000000565 A PE 2000000565A PE 0005652000 A PE0005652000 A PE 0005652000A PE 20010303 A1 PE20010303 A1 PE 20010303A1
Authority
PE
Peru
Prior art keywords
acid medium
labil
inhibitor
presentation
proton pump
Prior art date
Application number
PE2000000565A
Other languages
English (en)
Inventor
Rudolf Linder
Rango Dietrich
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7910295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010303(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PE20010303A1 publication Critical patent/PE20010303A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA FORMA DE PRESENTACION PARA AGENTES ACTIVOS LABILES EN MEDIO ACIDO QUE COMPRENDE ADYUVANTES FARMACEUTICOS; UNIDADES INDIVIDUALES MULTIPLES DE AGENTE ACTIVO TAL COMO MICROBOLAS CONTENIDO UN INHIBIDOR DE LAS BOMBAS DE PROTONES LABIL TAL COMO PANTOPRAZOL, CARACTERIZADO PORQUE EL AGENTE ACTIVO SE ENCUENTRA EN UNA MATRIZ CONSTITUIDA POR UNA MEZCLA QUE CONTIENE AL MENOS i)UN ALCOHOL GRASO; ii)UN TRIGLICERIDO; iii)UN ESTER DE ACIDO GRASO Y AL MENOS UNA PARAFINA SOLIDA; TAMBIEN PUEDE COMPRENDER LA FORMA DE PRESENTACION ADYUVANTES ADICIONALES TAL COMO POLIMEROS (POVIDONA, COPOLIMERO VINILPIRROLIDONA ACETATO DE VINILO, POLIACETATO DE VINILO, ETER DE CELULOSA, ENTRE OTROS), ESTEROLES (ERGOSTERINA, ESTIGMASTEROL, SITOSTEROL, ENTRE OTROS), COMPUESTOS BASICOS (CARBONATO DE AMONIO, CARBONATO DE SODIO, MEGLUMINA, TRIETILAMINA, ENTRE OTROS). TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION
PE2000000565A 1999-06-07 2000-06-07 Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido PE20010303A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19925710A DE19925710C2 (de) 1999-06-07 1999-06-07 Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer

Publications (1)

Publication Number Publication Date
PE20010303A1 true PE20010303A1 (es) 2001-03-09

Family

ID=7910295

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000565A PE20010303A1 (es) 1999-06-07 2000-06-07 Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido

Country Status (6)

Country Link
AR (1) AR024310A1 (es)
CO (1) CO5160296A1 (es)
DE (1) DE19925710C2 (es)
MY (1) MY138975A (es)
PE (1) PE20010303A1 (es)
TW (1) TWI255720B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
BR0115986A (pt) * 2000-12-07 2003-12-23 Altana Pharma Ag Comprimido de desintegração rápida contendo um ingrediente ativo instável aos ácidos
JP5009482B2 (ja) 2000-12-07 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性成分を含有する懸濁液の形の製薬製剤
CN100536844C (zh) * 2000-12-07 2009-09-09 尼科梅德有限责任公司 包含酸不稳定活性成分的糊剂形式的药物制剂
DE10061137B4 (de) * 2000-12-07 2016-10-06 Takeda Gmbh Neue pharmazeutische Zubereitung
DE10061138C1 (de) * 2000-12-07 2002-08-14 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form eines Saftes enthaltend einen säurelabilen Wirkstoff
DE10061136C1 (de) * 2000-12-07 2002-10-24 Byk Gulden Lomberg Chem Fab Schnell zerfallende Tablette enthaltend einen säurelabilen Protonenpumpenhemmer
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
CN1596104A (zh) 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 改进的释放剂型
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2490142A1 (en) * 2002-07-03 2004-01-15 Abbott Laboratories Liquid dosage forms of proton pump inhibitors
DE10244129B4 (de) * 2002-09-23 2006-04-20 Iongate Biosciences Gmbh H+-K+-ATPase-Assay
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
EP2258350B1 (en) 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2725924C3 (de) * 1977-06-08 1980-11-06 Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau Verfahren zur Herstellung kugelförmiger Teilchen aus niedrigschmelzenden organischen Substanzen
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法

Also Published As

Publication number Publication date
CO5160296A1 (es) 2002-05-30
DE19925710C2 (de) 2002-10-10
MY138975A (en) 2009-08-28
AR024310A1 (es) 2002-09-25
DE19925710A1 (de) 2000-12-14
TWI255720B (en) 2006-06-01

Similar Documents

Publication Publication Date Title
PE20010303A1 (es) Nueva preparacion y forma de presentacion que contiene un agente activo labil en medio acido que consiste en un inhibidor de la bomba de protones labil en medio acido
ES2542728T3 (es) Composiciones farmacéuticas que tienen la biodisponibilidad deseable
RU2005110945A (ru) Капсулы, содержащие водные наполняющие композиции, стабилизированные производным циклодекстрина
ES2625145T3 (es) Aplicación tópica y formulación de eritropoyetina para cicatrizar heridas cutáneas
PT1187601E (pt) Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido
AR032497A1 (es) Limpiador antimicrobiano acido para superficies duras
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
ES2155043B1 (es) Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion.
PE3296A1 (es) Composicion oral conteniendo un mucoadhesivo
CO5180575A1 (es) Composiciones antibacterianas orales de lupulona hidrogenda estable
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
FI956204A0 (fi) Stabiilit paikalliset retinoidikoostumukset
PT2116243E (pt) Composição de gel para tratamento de micoses
AR038681A1 (es) Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
PE20041024A1 (es) Sistema de liberacion controlada
BR0007360A (pt) Composição de liberação controlada
JP6081173B2 (ja) 眼科用水性組成物
MY143793A (en) Non-tabletted, chewable, individually dosed administration forms
CO5380014A1 (es) Formulacion farmaceuticas para la administracion oral o topica de compuestos hidrofobicos que no frma emulsion
NO820319L (no) Antimykotisk middel i form av stifter og med hoey virksom stoff frigjoering
PE20040545A1 (es) Formulaciones parasiticidas que comprenden benzoimidazoles o salicilanilidas en combinacion con lactonas macrociclicas
ES2530874T3 (es) Formulaciones de depósito de corta duración
PE17897A1 (es) Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
SE451666B (sv) Stabil bensoylperoxidkomposition
RU2165755C2 (ru) Композиция для лечения отита среднего уха с перфорацией и способ получения композиции

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed